May 18, 2021
This article was originally published on The Limbic Australian blood cancer patients are being denied access to life-extending drugs and treatments because of long delays and excessive regulation by the Pharmaceutical Benefits Advisory Committee (PBAC), a parliamentary inquiry has been told. Leading haematologist Professor Andrew Spencer said the registry of myeloma cases established some eight...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand